Cushman & Wakefield has strengthened its UK Valuation & Advisory business by appointing Martin Robb as Head of Healthcare Advisory.
Martin, a healthcare specialist, has worked in the sector for nearly 20 years. He has been involved in some of the largest advisory projects in the industry, such as Formation Capital’s purchase of NHP Plc and Omega Healthcare’s investment in Healthcare Homes.
More recently, he acted for CareTech and RBS in connection with CareTech’s innovative ground rent transaction with Alpha Real.
Martin’s appointment adds to Cushman & Wakefield’s UK Valuation & Advisory team of 235 professionals in 10 locations. In 2015, the team valued 59,000 properties worth a combined £549bn and retained its position as the market leader in several sectors including retail, Central London, business space, outlet malls and self-storage.
Recent capital inflows into UK healthcare, via the US REITs in particular, and a more competitive landscape amongst established UK funds and institutions has rapidly established healthcare as a recognised property investment class in its own right.
Martin Robb, who joins as a Senior Director, said: “It is exciting to be joining Cushman & Wakefield to establish a team that combines real estate knowledge with the detailed understanding of healthcare businesses’ underlying operating model that is necessary in order to add genuine value to clients in this sector.”
Charles Smith, Head of Valuation & Advisory UK, Cushman & Wakefield, added: “Martin’s impressive experience in the healthcare sector will be of enormous benefit to our business. We valued more than £18bn worth of alternative investments last year and as the UK’s leading valuation and advisory team are well placed to grow that considerably. Martin’s appointment will help us expand our service offering to build on our market-leading position.”
Martin is the latest senior recruit into Cushman & Wakefield’s Valuation & Advisory business, following Carl Ridgley who joined as a Director in the hospitality team earlier in the month.